Kezar Life Sciences Announces Presentations at Upcoming Scientific Conferences
March 28, 2019 16:05 ET
|
Kezar Life Sciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule...
Kezar Life Sciences Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
March 26, 2019 08:00 ET
|
Kezar Life Sciences, Inc.
Phase 1b SLE top-line data and Phase 2 LN initiation in Q2 2019Phase 2 trials in up to four additional autoimmune indications to begin 2H 2019First clinical candidate nomination for protein secretion...
Kezar Life Sciences Announces Initiation of Clinical Study to Test a New Drug Product Formulation of KZR-616
March 06, 2019 16:05 ET
|
Kezar Life Sciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule...
Kezar Life Sciences to Present at the Cowen and Company 39th Annual Health Care Conference
March 05, 2019 08:00 ET
|
Kezar Life Sciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule...
Kezar Life Sciences Strengthens Management Team, Appoints Celia Economides as Senior Vice President, Strategy and External Affairs
March 04, 2019 17:00 ET
|
Kezar Life Sciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule...
Kezar Life Sciences to Present at The BMO Prescriptions for Success Healthcare Conference
December 05, 2018 08:00 ET
|
Kezar Life Sciences, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule...
Kezar Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business Update
November 08, 2018 08:00 ET
|
Kezar Life Sciences, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule...
Kezar Life Sciences to Present at Jefferies 2018 London Healthcare Conference
November 07, 2018 08:00 ET
|
Kezar Life Sciences, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule...
Kezar Life Sciences to Present at 2018 Wells Fargo Healthcare Conference
August 29, 2018 08:00 ET
|
Kezar Life Sciences, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule...
Kezar Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update
August 09, 2018 16:05 ET
|
Kezar Life Sciences, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule...